: Adam Finn, Nigel Curtis, Andrew J. Pollard
: Adam Finn, Nigel Curtis, Andrew J. Pollard
: Hot Topics in Infection and Immunity in Children V
: Springer-Verlag
: 9780387798387
: 1
: CHF 133.00
:
: Klinische Fächer
: English
: 266
: Wasserzeichen/DRM
: PC/MAC/eReader/Tablet
: PDF

Course covers topics in infectious diseases in children and is intended for Pediatric Infectious disease trainees, trainers, and all those who manage children with infections.

This conference is being supported by several societies and is sponsored by several pharmaceutical companies, such as Aventis, Baxter, Chiron Vaccines, Wyeth, etc.

Preface6
Acknowledgments7
Contents8
Contributors10
Shiga-Toxin Producing Escherichia coli and the Hemolytic Uremic Syndrome: What Have We Learned in the Past 25 Years?14
1 Introduction14
2 History15
3 Epidemiology of E. coli O157:H7 Infections and HUS15
4 Clinical Course of E. coli Infection16
5 Pathophysiology of E. coli O157:H7 Infections17
6 Diagnostic Considerations for Pathogenic STEC17
7 Management of Patients with Confirmed or Suspected E. coli O157:H7 Infection19
8 HUS and the Course of E. coli O157:H7 Infections21
9 Pathophysiology of HUS23
10 Conclusions25
References26
Global Epidemiology of Pneumococcal Disease-New Prospects for Vaccine Control31
1 Overview of the Pneumococcus and Pneumococcal Disease31
2 Pneumonia32
3 Invasive Pneumococcal Disease32
4 Acute Otitis Media34
5 Pneumococcal Vaccines35
6 The Power of Pneumococcal Conjugate Vaccines I: Effect of PCV-7 on Rates of IPD in the US after Introduction in 200036
7 The Power of Pneumococcal Conjugate Vaccines II: Effect of the 11-Valent PHiD-Conjugate Vaccine on AOM in a Phase III Efficacy Trial37
8 Pneumococcal Vaccines for Adults38
9 Conclusions38
References39
Current Concepts of the Pathogenesis of RSV Bronchiolitis42
1 Introduction42
2 Genetic Determinants of RSV Bronchiolitis and Post-bronchiolitis Wheeze43
3 Pre-existent Airway Morbidity45
4 Immature Immune Responses45
5 Immunopathogenesis46
6 Parallel Versus Serial Hypothesis47
7 Conclusions48
References48
How Can We Eradicate Pertussis52
1 Introduction52
2 Bordetella pertussis: The Organism and Its Pathogenesis52
3 Clinical Disease53
3.1 Pertussis in Young Infants54
3.2 Adults54
4 Laboratory Diagnosis of B. pertussis Infection55
4.1 Culture55
4.2 Direct Detection of B. pertussis55
4.3 Serologic Diagnosis of B. pertussis Infection55
5 Epidemiology56
5.1 Reported Pertussis56
5.2 Epidemiology of B. pertussis Infections57
6 Vaccines59
7 Conclusions61
References61
Recognition and Management of Encephalitis in Children63
1 Introduction63
2 History63
3 Etiology64
4 Postimmunization Neurological Disease66
5 Postinfectious Encephalitis66
6 Chronic Encephalitic or Encephalopathic Illnesses (Slow Infections)67
7 Encephalitis Epidemiology67
8 Clinical Manifestations67
9 Differential Diagnosis68
10 Specific Diagnosis68
11 Treatment69
12 Prognosis70
13 Prevention70
References70
Microbiology and Management of Pleural Empyema71
1 Introduction71
2 Epidemiology and Aetiology72
2.1 Epidemiology72
2.2 Aetiology72
2.3 Risk Factors for Progression to Empyema73
3 Potential Reasons for Increasing Incidence of Empyema74
3.1 Serotype 174
3.2 Sequence Types74
4 Management75
4.1 Prevention75
4.2 Drainage of Fluid75
5 Summary76
References77
Pneumococcal Conjugate Vaccines Probe Studies: The Solution Points to the Problem79
1 Observed Versus Expected Effect of a Vaccine - The Vaccine Probe Concept79
2 Vaccine Probe-Derived Insights into PCVs - Selected Examples80
2.1 Probe Studies in Pneumonia - the pneumonia detective 80
3 Potential Role of PCVs in the Prevention of Mortality in Developing Populations82
4 Indirect Effect of PCV - the Herd Immunity Effect82
5 How Many Doses of PCV Are Appropriate for Infant Immunization Programs?83
6 Hypothesis Generating Results: A Study on Social Mixing During Infancy and Antibody Response to PCV7 at 1 Year of Age85
7 Conclusions85
References86
New Findings in Primary Immunodeficiency88
1 Introduction88
2 Severe Combined Immunodeficiency88
2.1 New T Lymphocyte Receptor Signalling Defects90
2.1.1 CD3 zeta Subunit Deficiency90
2.1.2 ORAI Deficiency90
2.2 New Defects of T and B Lymphocyte Receptor Recombination90
2.2.1 DNA Ligase IV Deficiency90
2.2.2 Cernunnos-XLF Deficiency91
3 X-Linked Lymphoproliferative Syndromes91
4 Common Variable Immunodeficiency92
4.1 Inducible Costimulator Deficiency92
4.2 CD19 Deficiency92
4.3 Transmembrane Activator and Calcium-Modulating Cyclophilin Lig